US CDC to expand surveillance of traveler samples for respiratory viruses

The US CDC said on Monday it was expanding testing of samples collected from international air travelers beyond COVID-19, to include flu and respiratory synctial virus (RSV) beginning November. The agency's traveler-based genomic surveillance program, or TGS, began in 2021 to help with early detection of new SARS-CoV-2 variants. CDC conducts voluntary nasal swabbing and airport wastewater sampling as part of it. The program includes seven participating international airports across the country - Los Angeles, New York's John F. Kennedy, San Francisco, Boston Logan, Washington Dulles, Seattle and Newark. "Our focus is always on airports that are international hubs and have flights coming in from a broad array of international locations so we can get a picture of what's going on globally and detect concerning strains early," said Cindy Friedman Chief of CDC's Travelers' Health Branch. Of the 6,000 nasal swab samples collected every week under the program, about 2,000 are tested for respiratory diseases, Friedman said, adding that nasal swabs from two of seven participating airports have been tested since October. Wastewater sampling from some of the airports began in November, Friedman added without providing details of the locations. The pilot expansion, which will last for several months, comes ahead of the US winter months when respiratory-disease causing viruses usually circulate more heavily.<br/>